CAP-22

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCAP-22
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLipid peroxidation inhibitorsGlycosylation inhibitorsCholesterol inhibitors +[4] 
TargetsCholesterolApolipoprotein B-100
Therapy Area/IndicationsDiabetes Complications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesGlycadia Inc
China Registration ClassN/A

Develop Information

Active CompaniesGlycadia Inc
Inactive CompaniesN/A
Active IndicationsDiabetes Complications
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A